BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+12.76%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$13.3B
AUM Growth
+$13.3B
Cap. Flow
+$1.04B
Cap. Flow %
7.8%
Top 10 Hldgs %
83.56%
Holding
125
New
10
Increased
16
Reduced
22
Closed
5

Top Buys

1
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$942M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
$155M
3
SGEN
Seagen Inc. Common Stock
SGEN
$97.6M
4
KNSA icon
Kiniksa Pharmaceuticals
KNSA
$52.1M
5
TCDA
Tricida, Inc. Common Stock
TCDA
$47.8M

Top Sells

1
AVXS
AveXis, Inc. Common Stock
AVXS
$144M
2
ABLX
Ablynx NV American Depositary Shares
ABLX
$119M
3
NKTR icon
Nektar Therapeutics
NKTR
$29.3M
4
EXEL icon
Exelixis
EXEL
$14M
5
PGNX
Progenics Pharmaceuticals Inc
PGNX
$10.7M

Sector Composition

1 Healthcare 92.39%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
$3.39B 25.46% 51,046,060 +1,470,651 +3% +$97.6M
INCY icon
2
Incyte
INCY
$16.5B
$2.29B 17.24% 34,251,034 +20,283 +0.1% +$1.36M
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$1.84B 13.81% 11,959,824 +6,130,395 +105% +$942M
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$1.06B 7.98% 8,555,894 – –
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.2B
$714M 5.37% 7,583,084 – –
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
$695M 5.22% 13,790,574 +638 +0% +$32.2K
ACAD icon
7
Acadia Pharmaceuticals
ACAD
$4.38B
$416M 3.12% 27,228,338 – –
MDGL icon
8
Madrigal Pharmaceuticals
MDGL
$9.76B
$327M 2.46% 1,169,278 +553,594 +90% +$155M
HRTX icon
9
Heron Therapeutics
HRTX
$207M
$195M 1.47% 5,025,298 – –
ASND icon
10
Ascendis Pharma
ASND
$11.8B
$189M 1.42% 2,837,352 – –
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$124M 0.93% 2,513,462 -35,999 -1% -$1.77M
ONCE
12
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$115M 0.86% 1,384,130 – –
DBVT
13
DBV Technologies
DBVT
$264M
$106M 0.8% 5,509,560 – –
SAGE
14
DELISTED
Sage Therapeutics
SAGE
$96M 0.72% 613,300 -33,528 -5% -$5.25M
ARRY
15
DELISTED
Array Biopharma Inc
ARRY
$94.9M 0.71% 5,656,196 – –
NBIX icon
16
Neurocrine Biosciences
NBIX
$13.8B
$92.8M 0.7% 944,624 – –
RYTM icon
17
Rhythm Pharmaceuticals
RYTM
$6.85B
$84.7M 0.64% 2,708,200 +659,180 +32% +$20.6M
BCRX icon
18
BioCryst Pharmaceuticals
BCRX
$1.74B
$80.3M 0.6% 14,012,172 – –
ARGX icon
19
argenx
ARGX
$43.6B
$79.7M 0.6% 961,754 – –
CERS icon
20
Cerus
CERS
$251M
$71.7M 0.54% 10,749,937 – –
AMRN
21
Amarin Corp
AMRN
$311M
$70M 0.53% 22,669,509 – –
CBAY
22
DELISTED
Cymabay Therapeutics
CBAY
$66M 0.5% 4,917,700 +1,000,000 +26% +$13.4M
NVTA
23
DELISTED
Invitae Corporation
NVTA
$61.7M 0.46% 8,399,411 – –
KNSA icon
24
Kiniksa Pharmaceuticals
KNSA
$2.48B
$52.1M 0.39% +3,000,000 New +$52.1M
ACGN
25
DELISTED
Aceragen, Inc. Common Stock
ACGN
$51M 0.38% 38,654,811 +13,349 +0% +$17.6K
1
2 3 4 5